LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

Home・Aandelen Lijst・Abbott Laboratories

Search

Abbott Laboratories

Gesloten

SectorGezondheidszorg

83.84 -0.56

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

82.61

Max

84.32

Belangrijke statistieken
By Trading Economics
Inkomsten	-699M 1.1B
Verkoop	-295M 11B
K/W Sectorgemiddelde	23.126 51.415
EPS	1.15
Dividendrendement	2.89
Winstmarge	9.647
Werknemers	122,000
EBITDA	-980M 1.8B

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+42.55% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	2.89% 2.34%
Volgende Winsten	16 jul 2026
Volgende dividenddatum	15 mei 2026
Volgende Ex Dividend datum	14 jul 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-31B 144B
Vorige openingsprijs	84.4
Vorige sluitingsprijs	83.84

Nieuwssentiment

By Acuity

48%

52%

155 / 346 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

132.82 / 134.43 Steun & Weerstand

Abbott Laboratories Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 apr 2026, 15:13 UTC

Winsten

Belangrijke Marktbewegers

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt 1Q Sales -- Update

16 apr 2026, 12:23 UTC

Winsten

Belangrijke Marktbewegers

Abbott Laboratories Cuts Outlook, Narrows 1Q Profit

22 jan 2026, 18:36 UTC

Winsten

Belangrijke Marktbewegers

Abbott Laboratories Raised Prices, Prompting Sales Slump -- Update

22 jan 2026, 13:23 UTC

Winsten

Belangrijke Marktbewegers

Abbott Laboratories 4Q Sales Grow, Outlook Underwhelms

16 apr 2026, 20:23 UTC

Winsten

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 apr 2026, 16:15 UTC

Winsten

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 apr 2026, 14:00 UTC

Marktinformatie

Winsten

A Mild Flu Season Hurt Abbott's Recent Quarter -- Market Talk

16 apr 2026, 13:59 UTC

Marktinformatie

Winsten

Abbott Laboratories Has Disappointing Quarter -- Market Talk

16 apr 2026, 12:05 UTC

Winsten

Acquisities, Fusies, Overnames

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. -- Barrons.com

16 apr 2026, 11:32 UTC

Winsten

Acquisities, Fusies, Overnames

Abbott Labs: 2026 EPS View Includes 20c Dilution Related to Exact Sciences Buy >ABT

16 apr 2026, 11:30 UTC

Winsten

Acquisities, Fusies, Overnames

Abbott Labs Sees 2Q Adj EPS $1.25-Adj EPS $1.31 >ABT

16 apr 2026, 11:30 UTC

Winsten

Acquisities, Fusies, Overnames

Abbott Labs Sees 2026 Comparable Sales Growth of 6.5%-7.5% >ABT

16 apr 2026, 11:30 UTC

Winsten

Acquisities, Fusies, Overnames

Abbott Labs Updates Guidance to Reflect Acquisition of Exact Sciences >ABT

16 apr 2026, 11:30 UTC

Winsten

Acquisities, Fusies, Overnames

Abbott Labs 1Q Sales $11.16B >ABT

16 apr 2026, 11:30 UTC

Winsten

Acquisities, Fusies, Overnames

Abbott Reports First-Quarter 2026 Results; Updates Guidance To Reflect Acquisition Of Exact Sciences >ABT

16 apr 2026, 11:30 UTC

Winsten

Acquisities, Fusies, Overnames

Abbott Labs 1Q Net $1.08B >ABT

16 apr 2026, 11:30 UTC

Winsten

Acquisities, Fusies, Overnames

Abbott Labs 1Q Adj EPS $1.15 >ABT

16 apr 2026, 11:30 UTC

Winsten

Acquisities, Fusies, Overnames

Abbott Labs Sees FY Adj EPS $5.38-Adj EPS $5.58 >ABT

16 apr 2026, 11:30 UTC

Winsten

Acquisities, Fusies, Overnames

Abbott Labs 1Q EPS 61c >ABT

11 apr 2026, 00:00 UTC

Winsten

Acquisities, Fusies, Overnames

Big Yachts, Big Bucks -- Barrons.com

23 mrt 2026, 12:50 UTC

Acquisities, Fusies, Overnames

Abbott Completes Acquisition Of Exact Sciences >ABT

20 mrt 2026, 13:01 UTC

Acquisities, Fusies, Overnames

Abbott Labs: Received All Regulatory Clearances for Exact Sciences Buy >ABT EXAS

20 mrt 2026, 13:00 UTC

Acquisities, Fusies, Overnames

Abbott Acquisition Of Exact Sciences Set To Close On March 23, 2026 >ABT

28 jan 2026, 14:48 UTC

Winsten

Abbott Stock Fell the Most in 23 Years After Earnings. The CEO Bought $2 Million of Shares. -- Barrons.com

23 jan 2026, 16:59 UTC

Winsten

Correction to Abbott Stock Drops Article on Jan. 22

22 jan 2026, 20:42 UTC

Winsten

Abbott Stock Is on Pace for Worst Day Since 2000. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22 jan 2026, 16:19 UTC

Winsten

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22 jan 2026, 15:22 UTC

Winsten

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes -- WSJ

22 jan 2026, 14:41 UTC

Populaire aandelen

Stocks to Watch Thursday: Intel, P&G, GE Aerospace -- WSJ

22 jan 2026, 14:08 UTC

Marktinformatie

Winsten

Abbott Posts Disappointing 4Q -- Market Talk

Peer Vergelijking

Prijswijziging

Abbott Laboratories Prognose

Koersdoel

By TipRanks

42.55% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 120.24 USD 42.55%

Hoogste 143 USD

Laagste 92 USD

Gebaseerd op 20 Wall Street-analisten die 12-maands prijsdoelen bieden voor Abbott Laboratories - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

20 ratings

16

Buy

4

Hold

0

Sell

Gebaseerd op 20 analisten die aandelenratings hebben gegeven aan Abbott Laboratories - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

132.82 / 134.43Steun & Weerstand

Bullish events outweigh bearish events.

The bullish and bearish events are balanced.

All events are bullish.

Sentiment

By Acuity

155 / 346 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,015.5

JNJ

Johnson and Johnson

230.41

ABBV

AbbVie Inc

208.54

UNH

UnitedHealth Group Inc

400.53

AZN

AstraZeneca PLC

187.75

Live chat